MD4410C1 - Balanced infusion solution - Google Patents

Balanced infusion solution

Info

Publication number
MD4410C1
MD4410C1 MDA20150042A MD20150042A MD4410C1 MD 4410 C1 MD4410 C1 MD 4410C1 MD A20150042 A MDA20150042 A MD A20150042A MD 20150042 A MD20150042 A MD 20150042A MD 4410 C1 MD4410 C1 MD 4410C1
Authority
MD
Moldova
Prior art keywords
infusion solution
balanced
sodium
balanced infusion
intoxications
Prior art date
Application number
MDA20150042A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4410B1 (en
MD20150042A2 (en
Inventor
Алексей Леонидович Коваленко
Андрей Юрьевич Петров
Original Assignee
Ecopharm Patent Management Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecopharm Patent Management Ag filed Critical Ecopharm Patent Management Ag
Publication of MD20150042A2 publication Critical patent/MD20150042A2/en
Publication of MD4410B1 publication Critical patent/MD4410B1/en
Publication of MD4410C1 publication Critical patent/MD4410C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine and pharmacology, namely to the saline infusion solutions having a detoxifying effect and can be used for treating diseases and conditions associated with organism intoxications of varying severity.Summary of the invention consists in that the balanced infusion solution comprises sodium, potassium and magnesium chlorides, sodium L-arginine succinate and water, in the following component ratio, mass %:
MDA20150042A 2014-05-20 2015-04-29 Balanced infusion solution MD4410C1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014120144/15A RU2549448C1 (en) 2014-05-20 2014-05-20 Balanced infusion solution

Publications (3)

Publication Number Publication Date
MD20150042A2 MD20150042A2 (en) 2015-12-31
MD4410B1 MD4410B1 (en) 2016-04-30
MD4410C1 true MD4410C1 (en) 2016-11-30

Family

ID=53289744

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150042A MD4410C1 (en) 2014-05-20 2015-04-29 Balanced infusion solution

Country Status (7)

Country Link
AR (1) AR099992A1 (en)
EA (1) EA024426B1 (en)
MD (1) MD4410C1 (en)
NI (1) NI201500056A (en)
PE (1) PE20151818A1 (en)
RU (1) RU2549448C1 (en)
UA (1) UA111116C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2676761C1 (en) * 2017-10-09 2019-01-11 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Polyionic infusion solution

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000879B1 (en) * 1998-12-02 2000-06-26 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Infusion solution ''reamberin''
EA001099B1 (en) * 1999-06-10 2000-10-30 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Injecting medical preparation "citoflavin" possessing cito-pretecting effect
EA007865B1 (en) * 2005-03-01 2007-02-27 Общество С Ограниченной Ответственностью "Палисандр" Disintoxicating infusion solution

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1395327A1 (en) * 1981-03-05 1988-05-15 Центральный научно-исследовательский институт гематологии и переливания крови Infusion solution for correcting metabolic alkalosis "sorbamin"
SU1630043A1 (en) * 1984-06-01 1994-02-28 Научно-исследовательский институт гематологии и переливания крови Plasma-substituting solution "maфусoл" for antishock therapy
RU2178296C1 (en) * 2000-06-20 2002-01-20 Государственный научный центр лекарственных средств Infusion solution to treat cardiovascular system diseases
RU2240116C1 (en) * 2003-08-20 2004-11-20 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Disintoxicating infusion solution
RU2006114834A (en) * 2003-10-03 2007-11-20 Оно Фармасьютикал Ко., Лтд. (Jp) INFUSION DRUG CONTAINING (2R) -2-PROPYLOCTANIC ACID AS AN ACTIVE INGREDIENT

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000879B1 (en) * 1998-12-02 2000-06-26 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Infusion solution ''reamberin''
EA001099B1 (en) * 1999-06-10 2000-10-30 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Injecting medical preparation "citoflavin" possessing cito-pretecting effect
EA007865B1 (en) * 2005-03-01 2007-02-27 Общество С Ограниченной Ответственностью "Палисандр" Disintoxicating infusion solution

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EA 001099 B1 30.10.2000 *
Реогемин. Регистрационное удостоверение Республики Беларусь РУ 12/12/2047 от 04.12.2012 *

Also Published As

Publication number Publication date
EA024426B1 (en) 2016-09-30
AR099992A1 (en) 2016-08-31
EA201401164A1 (en) 2015-11-30
RU2549448C1 (en) 2015-04-27
UA111116C2 (en) 2016-03-25
MD4410B1 (en) 2016-04-30
MD20150042A2 (en) 2015-12-31
PE20151818A1 (en) 2016-01-09
NI201500056A (en) 2015-09-08

Similar Documents

Publication Publication Date Title
MD20170020A2 (en) Compositions and methods of use for treating metabolic disorders
NZ738525A (en) Cot modulators and methods of use thereof
MX2016015997A (en) Preparation and use of crystalline beta-d-nicotinamide riboside.
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
MX2021010460A (en) Method of treatment with tradipitant.
MX2017011182A (en) Amylin analogues.
MX364220B (en) Methods of treating fibrosis.
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
PH12016502415A1 (en) Treatment of severe hypertriglyceridemia
TN2015000255A1 (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
MX2017012596A (en) A pharmaceutical composition and the use thereof.
PH12017500747B1 (en) Heterocyclic compound
EA201991175A1 (en) THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS
MX2015008310A (en) Method of treatment of hypoxia inducible factor (hif)-related conditions.
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
MX2016000037A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
PH12017500923A1 (en) New dosage and use of a a2a antagonist
MD4410B1 (en) Balanced infusion solution
MX2017009313A (en) Intravenous baclofen formulations and treatment methods.
PH12017500084A1 (en) Vitamin b2 and its use
IN2014MU01233A (en)
MX2017003604A (en) Dialysis solution.
MX2018011512A (en) Use of insulin for promoting gastric emptying.
MX2018004656A (en) Intravenous baclofen and methods of treatment.
TN2016000064A1 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees